Results 211 to 220 of about 37,913 (268)

Antimalarial compounds exhibit variant- and cell-type-specific activity against SARS-CoV-2 isolated in Panama. [PDF]

open access: yesFront Pharmacol
Quijada M   +12 more
europepmc   +1 more source

Antimalarials

Dermatologic Therapy, 2001
Antimalarial medications have become the parenteral drugs of choice for treating the cutaneous manifestations of lupus erythematosus. The immune-modulating activity of these agents makes them useful in a variety of other dermatoses. With prudent dosage and monitoring, these agents can be used safely and effectively in the treatment and management of ...
M J, Van Beek, W W, Piette
openaire   +2 more sources

Antimalarial combinations

The Lancet, 2004
Multidrug resistance has rendered monotherapy for malaria useless in most parts of the world, and has also compromised the usefulness of many of the available combination chemotherapies. New antimalarial regimens are, therefore, urgently needed. We review the various antimalarial combinations that can be used to treat otherwise drug-resistant disease ...
Peter Gottfried, Kremsner   +1 more
openaire   +2 more sources

Antimalarials

Journal of the American Academy of Dermatology, 1981
The antimalarials, chloroquine, hydroxychloroquine, and quinacrine, are used primarily for malaria; but they can be beneficial for cutaneous lupus erythematosus (LE), polymorphous light eruption, solar urticaria, and porphyria cutanea tarda. Antimalarials bind to deoxyribonucleic acid (DNA) which prevents DNA and ribonucleic acid (RNA) polymerase ...
openaire   +2 more sources

Home - About - Disclaimer - Privacy